Lillioja S, Foley J, Bogardus C, Mott D, Howard B V
Metabolism. 1986 Jun;35(6):505-14. doi: 10.1016/0026-0495(86)90006-5.
We have examined the relationship of free fatty acid (FFA) turnover and lipid oxidation rates in vivo to the size of body triglyceride stores and compared these findings with the in vitro lipolytic rates of isolated abdominal fat cells. The studies were performed in 20 Pima Indian women 18 to 35 years of age, both lean and obese. FFA turnover rate was measured using a 1-14C-palmitate infusion, lipid oxidation rate by indirect calorimetry using a ventilated hood, body composition by underwater weighing with correction for residual lung volume, and fat cell lipolytic rates in vitro by published methods. Both FFA turnover and lipid oxidation rates, expressed per kg of body fat, decreased with increasing degree of obesity (as measured by percent body fat) (r = -0.90, and r = -0.75, P less than or equal to 0.0001, respectively). In contrast, the rate of lipolysis determined in vitro, expressed per kg of fat, increased with increasing degree of obesity (r = 0.58, P less than 0.01). A ratio of FFA turnover/lipolysis, which directly compares these in vivo and in vitro measurements, decreased significantly with increases in the degree of obesity (r = -0.81, P less than or equal to 0.0001). Furthermore, there were no positive correlations between the measures of in vivo FFA metabolism and in vitro lipolysis when both were expressed per fat mass, per fat cell number, or per fat cell surface area. The in vivo data also demonstrated that lipid oxidation could only account for 50% of the FFA disappearance rate. While lipid oxidation rate adjusted to the metabolic size increased with increasing plasma FFA concentration (r = 0.75, P less than 0.0003), the nonoxidative component of the FFA turnover failed to increase with increases in plasma FFA concentration (P = 0.5). We conclude that FFA is not available in vivo in proportion to the size of the triglyceride stores. The reason for this is not due to an inability of fat cells to release their stored triglyceride as assessed in vitro. Hence, in vitro measurements of fat cell lipolysis cannot be used to directly predict in vivo FFA metabolism. The large nonoxidative FFA disposal is likely to be important in the regulation of plasma FFA concentrations.
我们研究了体内游离脂肪酸(FFA)周转率和脂质氧化率与体内甘油三酯储存量大小之间的关系,并将这些结果与分离的腹部脂肪细胞的体外脂肪分解率进行了比较。研究对象为20名年龄在18至35岁之间的皮马印第安女性,包括瘦人和肥胖者。使用1-14C-棕榈酸输注法测量FFA周转率,使用通风罩通过间接量热法测量脂质氧化率,通过水下称重并校正残气量来测量身体成分,并用已发表的方法测量体外脂肪细胞的脂肪分解率。以每千克体脂表示的FFA周转率和脂质氧化率均随着肥胖程度的增加(以体脂百分比衡量)而降低(r分别为-0.90和-0.75,P≤0.0001)。相反,以每千克脂肪表示的体外测定的脂肪分解率随着肥胖程度的增加而增加(r = 0.58,P<0.01)。直接比较这些体内和体外测量值的FFA周转率/脂肪分解率比值随着肥胖程度的增加而显著降低(r = -0.81,P≤0.0001)。此外,当以每脂肪量、每脂肪细胞数量或每脂肪细胞表面积表示时,体内FFA代谢指标与体外脂肪分解之间没有正相关。体内数据还表明,脂质氧化仅占FFA消失率的50%。虽然调整至代谢量的脂质氧化率随着血浆FFA浓度的增加而增加(r = 0.75,P<0.0003),但FFA周转率的非氧化成分并未随着血浆FFA浓度的增加而增加(P = 0.5)。我们得出结论,体内FFA的可用性与甘油三酯储存量的大小不成比例。其原因并非如体外评估的那样是脂肪细胞无法释放其储存的甘油三酯。因此,脂肪细胞脂肪分解的体外测量不能直接用于预测体内FFA代谢。大量的非氧化FFA处置可能在血浆FFA浓度的调节中起重要作用。